Bobojon ‘Bobo’ Nazarov - Ph.D., MBA, joined M.Ventures’ Healthcare Team in March 2018 as an Analyst. He graduated with a BSc (Hons) in Pharmacology and an MSc in Finance. Bobo started his career as a Financial Analyst in London where he honed his investment skills through structuring passive/active investment strategies, valuing exotic derivatives, and pricing spinout companies at Chicago Mercantile Exchange Group & HIS Markit. He also independently studied and passed Chartered Financial Analyst Levels I & II. Later he pursued an MSc in Pharmacology, a D.Phil. (Ph.D.) in System Biology and an MBA at the University of Oxford. Whilst in Oxford, his research focused on the mechanisms underlying cardiac disease with the aim of improving drug therapies. Bobo is based in Amsterdam.